BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Umbilical Cord

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Umbilical Cord:

Pubmed Logo
Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation.
Mesenchymal stem cells (MSCs) are considered to be a source of stem cells...
11th July, 2008
R&D, LifeCell International Pvt Ltd, 26, Vandalur Kelambakkam Main Road, J Tissue Eng Regen Med. 2008 Jul 10;.
DOI Direct Link
Inverted human umbilical arteries with tunable wall thicknesses for nerve regeneration.
Tubular nerve guides have shown a potential to bridge nerve defects, by...
11th July, 2008
School of Chemical, Biological and Materials Engineering, The University J Biomed Mater Res A. 2008 Jul 9;.
DOI Direct Link
The polymorphism in insulin receptor substrate-1 gene and birth weight in neonates at term.
Background: The mutation of the IRS-1 gene is one of the genetic risk...
11th July, 2008
Endokrynol Pol. 2008 May-Jun;59(3):212-6.
[Fetal pulse oximetry: Clinical practice.]
OBJECTIVE: To assess in current practice the application of our protocol...
11th July, 2008
Unite de gynecologie-obstetrique et medecine de la reproduction, CHU de J Gynecol Obstet Biol Reprod (Paris). 2008 Jul 7;.
DOI Direct Link
Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood.
For the past 40 years, bone marrow transplantation (BMT) has become...
11th July, 2008
Pluristem Therapeutics, Inc., MATAM Advanced Technology Park #20, Haifa Expert Opin Biol Ther. 2008 Aug;8(8):1241-50.
DOI Direct Link

View more research publications.

BioNews Results for Umbilical Cord:

RSS Logo
BioPortfolio Logo
Drugs Delivered via Umbilical Cord Stem Cells
Drug Discovery and Development:  Jul 12 2008 6:12AM Matching: umbilical cord
Umbilical cord stem cells transport anti-cancer drugs directly to tumors
Nanowerk:  Jul 10 2008 11:32PM Matching: umbilical cord
Umbilical Cord Stem Cells Transport Anti-Cancer Drugs Directly to Tumors
Newswise:  Jul 10 2008 7:09PM Matching: umbilical cord
Umbilical cord stem cells may offer treatment for hepatic diseases
NewKerala.com:  Jul 6 2008 1:53AM Matching: umbilical cord
Umbilical cord stem cells may offer treatment for hepatic diseases
NetIndia123.com:  Jul 5 2008 1:00PM Matching: umbilical cord
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Umbilical Cord Clinical Trials:

Clinical Trials Logo
Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
Acute Lymphocytic Leukemia;   Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin Lymphoma;   Chronic Myelogenous Leukemia
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
Breast Cancer;   Kidney Cancer;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant
Precancerous/Nonmalignant Condition

View more trials.

Umbilical Cord Patents:

USPTO Logo
US Patent No.Title
7371381 Anti-galanin antibodies and uses thereof
7375192 Antibodies that specifically bind to chemokine beta-4
7375237 Pyrrolizine compounds useful as anti-inflammatory agents
7378096 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
7378276 Method of inducing memory B cell development and terminal differentiation

View more patents.

Companies working in the area of Umbilical Cord from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Aastrom Biosciences Incorporated

Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing automated cell therapy systems designed to enable on-site cell production for therapeutic procedures using living cells in patients treated for...
www.aastrom.com/        View full profile
Thumbshot

Cord Blood America

Cord Blood America's mission is to be the most respected stem cell preservation company in the world. Cord Blood America will achieve its mission through educating expectant parents, families with a...
www.cordblood-america.com/        View full profile
Thumbshot

MediStem Laboratories

Medistem Laboratories is an innovative biotechnology company committed to the creation and commercialization of advanced medical therapies based on non-controversial adult stem cells. Medistem's...
www.medisteminc.com/        View full profile
Thumbshot

View more Umbilical Cord related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Umbilical Cord scientists - we have details of around 1440 individuals working on Umbilical Cord .


This page has been viewed 55 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Umbilical Cord across BioPortfolio, or bestselling Umbilical Cord books or recently published Umbilical Cord books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional